Recommendations for standards regarding preclinical neuroprotective and restorative drug development

Stroke

Volumn 30, Issue 12, 1999, Pages 2752-2758

  Fisher, Marc ^a  

^a University of Massachusetts   (United States)

Author keywords

Neuroprotection; Pharmacology; Stroke

Indexed keywords

NEUROPROTECTIVE AGENT;

ARTICLE; BRAIN ISCHEMIA; DRUG RESEARCH; DRUG SCREENING; HUMAN; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD; STROKE;

EID: 0344065373     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.12.2752     Document Type: Article

References (44)

1. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shikula R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-451.
2. American Heart Association. Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 1999.
3. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke. 1998;29: 705-718.
4. Fisher M. Characterizing the target of acute stroke therapy. Stroke. 1997;28: 866-872.
5. The National Institute of Neurological Disorders, and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
6. Furlan AJ, Higashida R, Wechsler L, Schulz G, for the PROACT II Investigators. PROACT II: recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: initial trial results. Stroke. 1999;30:234. Abstract.
7. Sherman DG, for the STAT Writers Group. Defibrinogenation with Viprinex™ (ancrod) for the treatment of acute ischemic stroke. Stroke. 1999; 30:234. Abstract.
8. Fisher M. Neuroprotection of acute ischemic stroke: where are we? The Neuroscientist. In press.
9. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances recovery following cerebral infarction in rats. J Cereb Blond Flow Metab. 1996;16:542-547.
10. Kawamata T, Ren J, Chan TCK, Charette M, Finklestein SP. Intracisternal osteogenic protein-1 enhances functional recovery following stroke. Neuroreport. 1998;9:1441-1445.
11. Tatlisumak T, Takano K, Carano RAD, Fisher M. Delayed treatment with an adenosine kinase inhibitor GP683 attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke. 1998;29:1952-1959.
12. Muir KW, Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1994;25:1755-1759.
13. Baron JC, von Kumar R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995; 26:2219-2221.
14. Ginsberg MD, Busto R. Small animal models of global and focal cerebral ischemia. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis and Management. Maiden, Mass: Blackwell Scientific Publications: 1998:14-35.
15. Koehler RC. Large animal models of focal and global ischemia. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. Malden, Mass: Blackwell Scientific Publications; 1998:36-51.
16. Beaulieu C, Busch E, Rother J, deCrespigny A, Hsia CJC, Moseley ME. Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: Potential mechanisms studied by magnetic resonance imaging. J Cereb Blood Flow Metab. 1998;18:1022-1031.
17. Chan PH. Role of oxidants in ischemic brain damage. Stroke. 1996;27: 1124-1129.
18. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke. 1998;29:529-534.
19. Coimbra C, Drake M, Boris-Moller F, Weiloch T. Long-lasting neuroprotective effect of post-ischemic hypothermia and treatment with an anti-inflammatory antipyretic drug. Stroke. 1996;77:1578-1585.
20. Valtyssow J, Hillered L, Andine P, Hagberg H, Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation. Acta Neurochir. 1994;129:58-63.
21. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) stroke. Neurology. 1998;50:864-870.
22. Zhang Z, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab. 1997;17:123-135.
23. Alkayed NJ, Harukuni I, Kimes AL, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke. 1998;29:159-166.
24. Toung TJK, Traystman RJ, Hurd PD. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke. 1998;29:1666-1670.
25. Hara H, Huang PL, Pawahian N, Fishman RC, Moskowitz MA. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab. 1996;16:605-611.
26. Eliasson MJL, Sampei K, Mandir AS, Hurn PD. Traystman RJ, Bao J, Pieper A, Wang Z-Q, Dawson TM, Snyder SH, Dawson VL. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 1997;3:1089-1095.
27. Onal MZ, Li F, Tatlisumak T, Locke KW, Sandage BW, Fisher M. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia. Stroke. 1997;28:1060-1065.
28. Zivin JA, Massarella V. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol. 1991;48: 1235-1235.
29. Nakayama H, Jorgensen HS, Rashou Ho, Olsen TS. Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehabil 1994;75:394-398.
30. Kawamata T, Dietrich DW, Schaller TT, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances functional recovery and upregulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A. 1997;94: 8179-8184.
31. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischemia in the rat, I: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:53-60.
32. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, Ginsberg MD. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 1992;575:238-246.
33. DeRyck M, Van Reempts J, Duytschaeser H, Van Deusen B, Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Res. 1992;573:44-60.
34. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855-857.
35. Stoemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 1998;29:2381-2395.
36. Jones TA, Schaller T. Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci. 1994;14:2140-2152.
37. Kolb B, Cote S, Ribeiro-da-Silva A, Cuello AC. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience. 1997;76:1139-1151.
38. Nudo RJ, Wise BM, Sifuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science. 1996;272:1791-1794.
39. Garcia JH, Kamijyo Y. Cerebral infarction: evolution of histopathological changes after occlusion of a middle cerebral artery in primates. 1974;33: 408-421.
40. Branston NM, Symon L, Crockard HA. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol. 1974;45:195-208.
41. Spetzler RF, Selman WR, Weinstein P, Townsend J, Mehdoric M, Telks D, Crummine RC, Macko R. Chronic reversible cerebral ischemia: evaluation of a new baboon model. J Neurosurg. 1980;7:257-261.
42. del Zoppo GJ, Copeland BR, Harker LA, Waltz TA, Zyroff J, Hanson SR, Battenberg E. Experimental acute thrombotic stroke in baboons. Stroke. 1986;17:1254-1265.
43. Young AR, Touzani O, Derlon J-M, Sette G, MacKenzie ET, Baron J-C. Early reperfusion in the anesthetized baboon reduces train damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume. Stroke. 1997;28:632-638.
44. Marshall JWB, Cross AJ, Ridley RM. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a non-human primate species. Exp Neurol. 1999;156:121-129.